Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; silica dimethyl silylate - indopril 2 is indicated for: the treatment of hypertension.the treatment of heart failure. in such patients it is recommended that indopril 2 be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril tablets have not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Canada - Engels - Health Canada

pro doc limitee - perindopril erbumine; indapamide - tablet - 4mg; 1.25mg - perindopril erbumine 4mg; indapamide 1.25mg

Canada - Engels - Health Canada

pro doc limitee - perindopril erbumine; indapamide - tablet - 8mg; 2.5mg - perindopril erbumine 8mg; indapamide 2.5mg

Australië - Engels - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - indapamide hemihydrate,perindopril erbumine -

Verenigde Staten - Engels - NLM (National Library of Medicine)

xoma (us) llc - perindopril erbumine (unii: 1964x464oj) (perindoprilat - unii:2uv6znq92k) - perindopril erbumine 2 mg - aceon is indicated for the treatment of patients with essential hypertension. aceon may be used alone or given with other classes of antihypertensives, especially thiazide diuretics. aceon is indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. aceon can be used with conventional treatment for management of coronary artery disease, such as antiplatelet, antihypertensive or lipid-lowering therapy. aceon® (perindopril erbumine) is contraindicated in patients known to be hypersensitive (including angioedema) to this product or to any other ace inhibitor. aceon is also contraindicated in patients with hereditary or idiopathic angioedema. do not co-administer aliskiren with aceon in patients with diabetes [see drug interactions (7.8)] . pregnancy category d [see boxed warning and warnings and precautions (5.4) ]. use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregna

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

clinect nz pty limited - perindopril erbumine 2mg - tablet - 2 mg - active: perindopril erbumine 2mg excipient: lactose magnesium stearate - perindopril is indicated for: · the treatment of hypertension.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

clinect nz pty limited - perindopril erbumine 4mg - tablet - 4 mg - active: perindopril erbumine 4mg excipient: lactose magnesium stearate - perindopril is indicated for: · the treatment of hypertension.